Patents by Inventor Thomas Stöhr

Thomas Stöhr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190175613
    Abstract: The present invention relates to Orally Inhaled and Nasal Drug Product (OINDP) comprising a benzodiazepine, in particular remimazolam.
    Type: Application
    Filed: April 18, 2017
    Publication date: June 13, 2019
    Applicant: Paion UK Limited
    Inventors: Karl-Uwe Petersen, Derek Jo Sakata, Thomas Stöhr, John Graham, Brett Cooper, Tatjana Bevans, Christopher Reilly
  • Patent number: 10090534
    Abstract: An electrochemical system is described having an end plate, a stack cover plate adjacent to the end plate and at least one metallic electrical conductor. The stack cover plate has an electrically conductive contacting plate adjacent to the end plate and an electrically conductive separator plate half facing away from the end plate. The contacting plate and the separator plate half are connected to each other electrically and media-tight. The metallic electrical conductor extends to an outside of the electrochemical system. The metallic electrical conductor and the contacting plate are in one piece or the metallic electrical conductor contacts the contacting plate directly. The contacting plate and the separator plate half are bonded to each other.
    Type: Grant
    Filed: September 29, 2015
    Date of Patent: October 2, 2018
    Assignee: Reinz-Dichtungs-GmbH
    Inventors: Andre Speidel, Joachim Scherer, Thomas Stoehr
  • Patent number: 10084195
    Abstract: The application relates to a water transfer compound, preferably for use for the humidification of process gases for fuel cells, comprising:—a water-permeable and essentially gas-impermeable water transfer layer as well as—at least one thermoplastic protection layer which is water- and gas-permeable at least in sections, where—the water transfer layer and the thermoplastic protection layer overlap each other at least in sections and comprise a first and a second overlapping area, where—the water transfer layer in the first overlapping area is accessible for humid gases through the thermoplastic protection layer and the water transfer compound is thermocompressed in the second overlapping area so that the water transfer layer in the second overlapping area is not accessible for humid gases through the compressed thermoplastic protection layer.
    Type: Grant
    Filed: October 5, 2015
    Date of Patent: September 25, 2018
    Assignee: Reinz-Dichtungs GmbH
    Inventors: Joachim Scherer, Rainer Glueck, Thomas Stoehr, Werner Buntz, Manfred Bruehl
  • Publication number: 20170324099
    Abstract: A separator plate for an electrochemical system has two metal individual plates. The plates have passage openings for operating media and possibly coolant, and distribution structures. The distribution structures are formed in the metal individual plates and which each communicate with at least two of the passage openings. A peripherally extending sealing structure is formed in each of the metal individual plates at least peripherally around the electrochemically active region and at a distance therefrom and/or peripherally around at least one of the passage openings and at a distance from the edge thereof. The cross-section of the sealing structure has a bead roof, two bead flanks, and at least in some segments, two bead feet. At least in the region of the bead roof of the sealing structure at least in some segments, the sealing structure extends sinuously with at least two wave periods having convex and concave segments.
    Type: Application
    Filed: October 16, 2015
    Publication date: November 9, 2017
    Applicant: REINZ-DICHTUNGS-GMBH
    Inventors: THOMAS STOEHR, CLAUDIA KUNZ, STEPHAN WENZEL
  • Patent number: 9446011
    Abstract: The present invention is directed to a pharmaceutical composition comprising a Compound (a) of a class of peptide Compounds and at least one further Compound (b) for the prevention, alleviation or/and treatment of epileptic seizures.
    Type: Grant
    Filed: March 31, 2015
    Date of Patent: September 20, 2016
    Assignee: UCB PHARMA GMBH
    Inventor: Thomas Stöhr
  • Publication number: 20160102410
    Abstract: An electrochemical system is described having an end plate, a stack cover plate adjacent to the end plate and at least one metallic electrical conductor. The stack cover plate has an electrically conductive contacting plate adjacent to the end plate and an electrically conductive separator plate half facing away from the end plate. The contacting plate and the separator plate half are connected to each other electrically and media-tight. The metallic electrical conductor extends to an outside of the electrochemical system. The metallic electrical conductor and the contacting plate are in one piece or the metallic electrical conductor contacts the contacting plate directly. The contacting plate and the separator plate half are bonded to each other.
    Type: Application
    Filed: September 29, 2015
    Publication date: April 14, 2016
    Inventors: Andre Speidel, Joachim Scherer, Thomas Stoehr
  • Patent number: 9308183
    Abstract: The present invention is directed to the use of a class of peptide compounds for treating diseases associated with hyperexcitability. The present invention is also directed to the use of a class of peptide compounds for treating diseases associated with dysfunction of an ion channel.
    Type: Grant
    Filed: June 29, 2007
    Date of Patent: April 12, 2016
    Assignee: UCB PHARMA GMBH
    Inventors: Cara Heers, Thomas Stoehr, Bettina Beyreuther
  • Publication number: 20160079615
    Abstract: The application relates to a water transfer compound, preferably for use for the humidification of process gases for fuel cells, comprising:—a water-permeable and essentially gas-impermeable water transfer layer as well as—at least one thermoplastic protection layer which is water- and gas-permeable at least in sections, where—the water transfer layer and the thermoplastic protection layer overlap each other at least in sections and comprise a first and a second overlapping area, where—the water transfer layer in the first overlapping area is accessible for humid gases through the thermoplastic protection layer and the water transfer compound is thermocompressed in the second overlapping area so that the water transfer layer in the second overlapping area is not accessible for humid gases through the compressed thermoplastic protection layer.
    Type: Application
    Filed: April 4, 2014
    Publication date: March 17, 2016
    Applicant: REINZ-DICHTUNGS-GMBH
    Inventors: JOACHIM SCHERER, RAINER GLUECK, THOMAS STOEHR, WERNER BUNTZ, MANFRED BRUEHL
  • Publication number: 20160056483
    Abstract: The application relates to a water transfer compound, preferably for use for the humidification of process gases for fuel cells, comprising: —a water-permeable and essentially gas-impermeable water transfer layer as well as—at least one thermoplastic protection layer which is water- and gas-permeable at least in sections, where—the water transfer layer and the thermoplastic protection layer overlap each other at least in sections and comprise a first and a second overlapping area, where—the water transfer layer in the first overlapping area is accessible for humid gases through the thermoplastic protection layer and the water transfer compound is thermocompressed in the second overlapping area so that the water transfer layer in the second overlapping area is not accessible for humid gases through the compressed thermoplastic protection layer.
    Type: Application
    Filed: October 5, 2015
    Publication date: February 25, 2016
    Applicant: REINZ-DICHTUNGS-GMBH
    Inventors: JOACHIM SCHERER, RAINER GLUECK, THOMAS STOEHR, WERNER BUNTZ, MANFRED BRUEHL
  • Patent number: 9095557
    Abstract: The present invention is directed to a pharmaceutical composition comprising a Compound (a) of a class of peptide Compounds and at least one further Compound (b) for the prevention, alleviation or/and treatment of epileptic seizures.
    Type: Grant
    Filed: November 14, 2013
    Date of Patent: August 4, 2015
    Assignee: UCB PHARMA GMBH
    Inventor: Thomas Stöhr
  • Publication number: 20150202184
    Abstract: The present invention is directed to a pharmaceutical composition comprising a Compound (a) of a class of peptide Compounds and at least one further Compound (b) for the prevention, alleviation or/and treatment of epileptic seizures.
    Type: Application
    Filed: March 31, 2015
    Publication date: July 23, 2015
    Inventor: Thomas Stöhr
  • Patent number: 8828943
    Abstract: A method for alleviating and/or treating epileptic seizures comprising administering a pharmaceutical composition comprising (a) lacosamide and/or a pharmaceutically acceptable salt thereof; and (b) levetiracetam and/or a pharmaceutically acceptable salt thereof is described.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: September 9, 2014
    Assignee: UCB Pharma GmbH
    Inventor: Thomas Stöhr
  • Patent number: 8735356
    Abstract: A pharmaceutical composition comprising a Compound (a) of a class of peptide Compounds and at least one further Compound (b) for the prevention, alleviation and/or treatment of epileptic seizures.
    Type: Grant
    Filed: June 15, 2007
    Date of Patent: May 27, 2014
    Assignee: UCB Pharma GmbH
    Inventor: Thomas Stoehr
  • Publication number: 20140128377
    Abstract: The present invention is directed to the use of a class of peptide Compounds for prevention, alleviation or/and treatment of refractory Status epilepticus.
    Type: Application
    Filed: January 14, 2014
    Publication date: May 8, 2014
    Applicant: UCB Pharma GmbH
    Inventor: Thomas STÖHR
  • Publication number: 20140128378
    Abstract: The present invention is directed to the use of a class of peptide Compounds for prevention, alleviation or/and treatment of refractory Status epilepticus.
    Type: Application
    Filed: January 14, 2014
    Publication date: May 8, 2014
    Applicant: UCB Pharma GmbH
    Inventor: Thomas STÖHR
  • Publication number: 20140088168
    Abstract: The present invention is directed to a pharmaceutical composition comprising a Compound (a) of a class of peptide Compounds and at least one further Compound (b) for the prevention, alleviation or/and treatment of epileptic seizures.
    Type: Application
    Filed: November 14, 2013
    Publication date: March 27, 2014
    Applicant: UCB Pharma GmbH
    Inventor: Thomas Stöhr
  • Publication number: 20140066515
    Abstract: The present invention is directed to the use of a class of peptide compounds for treating diseases associated with hyperexcitability. The present invention is also directed to the use of a class of peptide compounds for treating diseases associated with dysfunction of an ion channel.
    Type: Application
    Filed: September 10, 2013
    Publication date: March 6, 2014
    Applicant: UCB Pharma GmbH
    Inventors: Cara Heers, Thomas Stoehr, Bettina Beyreuther
  • Patent number: 8536137
    Abstract: The present invention is directed to the use of a class of peptide compounds for treating tumor pain, in particular bone cancer pain, for treating chemotherapy-induced pain and for treating nucleoside-induced pain.
    Type: Grant
    Filed: October 12, 2009
    Date of Patent: September 17, 2013
    Assignee: UCB Pharma GmbH
    Inventors: Bettina Beyreuther, Thomas Stöhr
  • Patent number: 8338641
    Abstract: The present invention is directed to the use of a class of peptide compounds for treating pain in trigeminal neuralgia.
    Type: Grant
    Filed: June 16, 2010
    Date of Patent: December 25, 2012
    Assignee: UCB Pharma GmbH
    Inventors: Thomas Stöhr, Christine Rauschkolb-Loeffler
  • Publication number: 20120238614
    Abstract: The present invention is directed to a pharmaceutical composition comprising a Compound (a) of a class of peptide Compounds and at least one further Compound (b) for the prevention, alleviation or/and treatment of epileptic seizures.
    Type: Application
    Filed: March 23, 2012
    Publication date: September 20, 2012
    Applicant: UCB Pharma GmbH
    Inventor: Thomas Stöhr